With a focus on phosphorylation, glycosylation, citrullination, and other critical PTMs, we highlight how these modifications influence the aggregation, clearance, and toxicity of key proteins like tau and amyloid precursor protein (APP) involved in AD pathogenesis. The gene discussed is MAPT; the disease is Alzheimer disease.